作者
Avi Sabbag, Benjamin Essayagh, Juan David Ramírez Barrera, Cristina Basso, Ana Berni, Bernard Cosyns, Jean-Claude Deharo, Thomas Deneke, Luigi Di Biase, Maurice Enriquez-Sarano, Erwan Donal, Katsuhiko Imai, Han S Lim, Nina Ajmone Marsan, Mohit K Turagam, Petr Peichl, Sunny S Po, Kristina Hermann Haugaa, Dipen Shah, Marta de Riva Silva, Philippe Bertrand, Magdi Saba, Marc Dweck, Santiago Nava Townsend, Tachapong Ngarmukos, Guilherme Fenelon, Pasquale Santangeli, Leyla Elif Sade, Domenico Corrado, Pier Lambiase, Prashanthan Sanders, Etienne Delacrétaz, Arshad Jahangir, Elizabeth S Kaufman, Daljeet Kaur Saggu, Luc Pierard, Victoria Delgado, Patrizio Lancellotti
发表日期
2022/12/1
期刊
Europace
卷号
24
期号
12
页码范围
1981-2003
出版商
Oxford University Press
简介
Risk stratification scheme. Risk stratification aiming at assessing the risk of VAs and SCD in patients with MVP, involving two phases based on the clinical and imaging context and the uncovered arrhythmia. In the absence of ventricular tachycardia, phenotypic risk features will trigger the intensity of screening for arrhythmia. Green boxes indicate green heart consensus statements and yellow boxes indicate yellow heart consensus statements. High risk-sustained VT, polymorphic NSVT, fast (> 180 bpm) NSVT, VT/NSVT resulting in syncope. ICD= implantable cardioverter defibrillator; LA= left atrium; LGE= late gadolinium enhancement; LV-EF= left ventricular ejection fraction; MAD= mitral annular disjunction; MV= mitral valve; PVCs= premature ventricular contractions; TWI= T-wave inversion; VT= ventricular tachycardia.# Additional ECG monitoring method may be used such as loop recorders.
引用总数